We previously reported in ischemic
acute kidney injury (AKI) in mice that caspase-1-mediated production of
interleukin-18 (IL-18) is pathogenic and that macrophage depletion by
liposome-encapsulated
clodronate (LEC) is protective. Therefore, our aim was to determine whether macrophages are a source of
IL-18 in ischemic AKI in mice. On immunofluorescence staining of the outer stripe of outer medulla, the number of macrophages double stained for CD11b and
IL-18 was significantly increased in AKI and significantly decreased by LEC. Adoptive transfer of RAW 264.7 cells, a mouse macrophage line that constitutively expresses
IL-18 mRNA, reversed the functional protection against AKI in both LEC-treated wild-type and caspase-1 -/- mice. To test whether
IL-18 in macrophages is necessary to cause AKI, we adoptively transferred macrophages in which
IL-18 was inhibited. Peritoneal macrophages isolated from wild-type mice,
IL-18 binding protein transgenic (IL-18 BP Tg) mice, and
IL-18 -/- mice were used.
IL-18 BP Tg mice overexpress human
IL-18 BP and exhibit decreased
biological activity of
IL-18. Adoptive transfer of peritoneal macrophages from wild-type as well as
IL-18 BP Tg and
IL-18 -/- mice reversed the functional protection against AKI in LEC-treated mice. In summary, adoptive transfer of RAW cells, that constitutively express
IL-18, reverses the functional protection in macrophage-depleted wild-type and caspase-1 -/- mice with AKI. However, adoptive transfer of peritoneal macrophages in which
IL-18 function was inhibited also reverses the functional protection in macrophage-depleted mice. In conclusion,
IL-18 from adoptive transfer of macrophages is not sufficient to cause ischemic AKI.